Dr. Anamika K. Patel, MD

Dr. Patel practices at Robert Wood Johnson University Hospital Hamilton in Hamilton, New Jersey, part of RWJBarnabas Health.

Dr. Patel's NPI, 1700892494, was assigned on August 1, 2006. Dr. Patel holds New Jersey license MA77694.

Dr. Patel's primary practice is Robert Wood Johnson University Hospital Hamilton, at One Hamilton Health Place, Hamilton, NJ 08690 in Mercer County. The practice phone is (609) 586-7900. Dr. Patel also practices at Robert Wood Johnson University Hospital - Hamilton, 1 Hamilton Health Pl, Trenton, NJ 08690.

Dr. Patel's primary practice is Robert Wood Johnson University Hospital Hamilton in Hamilton, New Jersey, part of RWJBarnabas Health. Dr. Patel is also affiliated with Capital Health Regional Medical Center. The medical group on file is ID Care. Dmand AI also links Dr. Patel to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Patel is licensed in New Jersey.

CMS data shows 3,075 Medicare services from Dr. Patel across 11 procedure codes in 2024, for 979 Medicare patients. Medicare paid $277,248 for them.

CMS counts 979 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 321 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 67, with 45% women.

In 2024, Dr. Patel wrote 868 Medicare Part D claims for 200 patients. 60% of them were for generic drugs. CMS names the drug for 725 of them, across 31 drugs with 11 or more claims each, at $1,084,977 in total drug cost. In 2023, CMS named 588 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

CMS Open Payments shows 469 general payments to Dr. Patel from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Gilead Sciences, Inc. paid the most, $1,325.